With Low Dose Allergy (LDA) therapy we have the ability to
treat most forms of allergies: foods, inhalants, chemical sensitivities, etc.
Low Dose Allergen (LDA) therapy is an amazing option for treating most forms of allergies. This includes most forms of inhaled allergens (hay fever, pollen, pet dander, etc.), food allergens (dairy, gluten, corn, etc.), and even chemical sensitivities (perfumes, formaldehyde, etc.).
LDA therapy stems from the research of Dr. Leonard McEwen, a British physician who developed Enzyme Potentiated Desensitization (EPD) therapy out of research done in the 1960’s. This was used quite successfully here in the U.S. until 2002 when it was banned by the FDA. Dr. Butch Shrader continued Dr. McEwen’s research and developed a next-generation form of the same kind of therapy he named Low Dose Allergen (LDA) therapy.
HOW IT WORKS
With LDA therapy hundreds of different antigens (things people might be allergic to) are premixed and injected into the skin along with an enzyme called “beta glucuronidase.” This enzyme tells your body to quit reacting to those antigens so much. It does this by raising the levels of the T-Regulator cells, which calm down the immune response to that particular antigen.
NOT AN "ALLERGY SHOT"
At first glance, LDA appears similar to “regular allergy shots.” Both involve intermittent injections to treat allergic conditions. But that’s where the similarities end.
- Working by a different mechanism
- MUCH lower doses (making it safer)
- Hundreds of premixed antigens
- No need for allergy testing
- Shots given much less often
- Given into the skin instead of under it
Low Dose Immunotherapy (LDI) aims to treat different
autoimmune disorders, Parkinson’s disease, Lyme disease, and more.
Low Dose Immunotherapy (LDI) is a almost identical to the Low Dose Allergy (LDA) therapy. While LDA works very well for many types of allergies, LDI can work for various autoimmune disorders and chronic infections.
LDA VS. LDI
After Dr. Shrader developed LDA for multiple different types of allergies, he noted that various autoimmune disorders tended to be associated with possible low-lying infections caused by various bacteria. He made some LDA formulations using antigens for some of these, and had very good success treating several different autoimmune disorders including Rheumatoid Arthritis, Crohn’s, and others. Dr. Ty Vincent later came along and extended the idea to treat Lyme Disease and came up with several other formulations which work very well for several other diseases and infections. Probably the biggest difference between LDA and LDI is who came up with the therapy – Dr. Shrader trademarked the LDA name, so Dr. Vincent coined LDI. There are also some differences in how they are dosed and used – LDA typically has relatively fixed doses while LDI requires everyone to have their own specific dose. Typically with LDI, if you give a dose that’s too high you can make the disease symptoms worse, too low a dose will usually do nothing, and “just right” can potentially work wonders. Because of the possibility of dosing too high, we often start at a dose we think will be too low and work up from there.